Enzyme Kinetics of PAPS-Sulfotransferase.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 17 7 2021
pubmed: 18 7 2021
medline: 24 8 2021
Statut: ppublish

Résumé

The cytosolic sulfotransferase (SULT) enzymes are found in human liver, kidney, intestine, and other tissues. These enzymes catalyze the transfer of the -SO

Identifiants

pubmed: 34272699
doi: 10.1007/978-1-0716-1554-6_11
doi:

Substances chimiques

Xenobiotics 0
PAPS sulfotransferase EC 1.8.4.8
Sulfotransferases EC 2.8.2.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

285-300

Informations de copyright

© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Williams RT (1959) Detoxication mechanisms the metabolism and detoxication of drugs, toxic substances and other organic compounds. Chapman and Hall, Ltd., London
Coughtrie MWH (2016) Function and organization of the human cytosolic sulfotransferase (SULT) family. Chem Biol Interact 259(Pt A):2–7. https://doi.org/10.1016/j.cbi.2016.05.005
doi: 10.1016/j.cbi.2016.05.005 pubmed: 27174136
Gunal S, Hardman R, Kopriva S, Mueller JW (2019) Sulfation pathways from red to green. J Biol Chem 294(33):12293–12312. https://doi.org/10.1074/jbc.REV119.007422
doi: 10.1074/jbc.REV119.007422 pubmed: 31270211 pmcid: 6699852
Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, Coughtrie MW (2004) A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14(3):199–211
doi: 10.1097/00008571-200403000-00009
Riches Z, Stanley EL, Bloomer JC, Coughtrie MW (2009) Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT “pie”. Drug Metab Dispos 37(11):2255–2261. https://doi.org/10.1124/dmd.109.028399 . dmd.109.028399 [pii]
doi: 10.1124/dmd.109.028399 pubmed: 19679676 pmcid: 2774979
Fritz A, Busch D, Lapczuk J, Ostrowski M, Drozdzik M, Oswald S (2019) Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: an intra-subject analysis. Basic Clin Pharmacol Toxicol 124(3):245–255. https://doi.org/10.1111/bcpt.13137
doi: 10.1111/bcpt.13137 pubmed: 30253071
Miki Y, Nakata T, Suzuki T, Darnel AD, Moriya T, Kaneko C, Hidaka K, Shiotsu Y, Kusaka H, Sasano H (2002) Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues. J Clin Endocrinol Metab 87(12):5760–5768
doi: 10.1210/jc.2002-020670
Teubner W, Meinl W, Florian S, Kretzschmar M, Glatt H (2007) Identification and localization of soluble sulfotransferases in the human gastrointestinal tract. Biochem J 404(2):207–215. https://doi.org/10.1042/BJ20061431 . BJ20061431 [pii]
doi: 10.1042/BJ20061431 pubmed: 17335415 pmcid: 17335415
Foster PA, Mueller JW (2018) Sulfation pathways: insights into steroid sulfation and desulfation pathways. J Mol Endocrinol 61(2):T271–T283. https://doi.org/10.1530/JME-18-0086
doi: 10.1530/JME-18-0086 pubmed: 29764919
Piccinato CA, Neme RM, Torres N, Sanches LR, Derogis P, Brudniewski HF, Rosa ESJC, Ferriani RA (2016) Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells. J Steroid Biochem Mol Biol 158:117–126. https://doi.org/10.1016/j.jsbmb.2015.12.025
doi: 10.1016/j.jsbmb.2015.12.025 pubmed: 26723541
Runge-Morris M, Kocarek TA (2013) Expression of the sulfotransferase 1C family: implications for xenobiotic toxicity. Drug Metab Rev 45(4):450–459. https://doi.org/10.3109/03602532.2013.835634
doi: 10.3109/03602532.2013.835634 pubmed: 24028175
Bendadani C, Meinl W, Monien B, Dobbernack G, Florian S, Engst W, Nolden T, Himmelbauer H, Glatt H (2014) Determination of sulfotransferase forms involved in the metabolic activation of the genotoxicant 1-hydroxymethylpyrene using bacterially expressed enzymes and genetically modified mouse models. Chem Res Toxicol 27(6):1060–1069. https://doi.org/10.1021/tx500129g
doi: 10.1021/tx500129g pubmed: 24802129
Martati E, Boersma MG, Spenkelink A, Khadka DB, van Bladeren PJ, Rietjens IM, Punt A (2012) Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats. Toxicol Sci 128(2):301–316. https://doi.org/10.1093/toxsci/kfs174
doi: 10.1093/toxsci/kfs174 pubmed: 22588462
Negishi M, Pedersen LG, Petrotchenko E, Shevtsov S, Gorokhov A, Kakuta Y, Pedersen LC (2001) Structure and function of sulfotransferases. Arch Biochem Biophys 390(2):149–157. https://doi.org/10.1006/abbi.2001.2368 . S0003-9861(01)92368-9 [pii]
doi: 10.1006/abbi.2001.2368 pubmed: 11396917
Tibbs ZE, Rohn-Glowacki KJ, Crittenden F, Guidry AL, Falany CN (2015) Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis. Drug Metab Pharmacokinet 30(1):3–20. https://doi.org/10.1016/j.dmpk.2014.10.004
doi: 10.1016/j.dmpk.2014.10.004 pubmed: 25760527
Gamage NU, Tsvetanov S, Duggleby RG, McManus ME, Martin JL (2005) The structure of human SULT1A1 crystallized with estradiol. An insight into active site plasticity and substrate inhibition with multi-ring substrates. J Biol Chem 280(50):41482–41486. https://doi.org/10.1074/jbc.M508289200 . M508289200 [pii]
doi: 10.1074/jbc.M508289200 pubmed: 16221673
Venkatachalam KV, Akita H, Strott CA (1998) Molecular cloning, expression, and characterization of human bifunctional 3′-phosphoadenosine 5′-phosphosulfate synthase and its functional domains. J Biol Chem 273(30):19311–19320. https://doi.org/10.1074/jbc.273.30.19311
doi: 10.1074/jbc.273.30.19311 pubmed: 9668121
Fuda H, Shimizu C, Lee YC, Akita H, Strott CA (2002) Characterization and expression of human bifunctional 3′-phosphoadenosine 5′-phosphosulphate synthase isoforms. Biochem J 365(Pt 2):497–504. https://doi.org/10.1042/BJ20020044
doi: 10.1042/BJ20020044 pubmed: 11931637 pmcid: 1222679
Cappiello M, Franchi M, Giuliani L, Pacifici GM (1989) Distribution of 2-naphthol sulphotransferase and its endogenous substrate adenosine 3′-phosphate 5′-phosphosulphate in human tissues. Eur J Clin Pharmacol 37(3):317–320. https://doi.org/10.1007/BF00679793
doi: 10.1007/BF00679793 pubmed: 2612547
Cappiello M, Giuliani L, Pacifici GM (1991) Distribution of UDP-glucuronosyltransferase and its endogenous substrate uridine 5′-diphosphoglucuronic acid in human tissues. Eur J Clin Pharmacol 41(4):345–350. https://doi.org/10.1007/BF00314965
doi: 10.1007/BF00314965 pubmed: 1804651
Leyh TS, Cook I, Wang T (2013) Structure, dynamics and selectivity in the sulfotransferase family. Drug Metab Rev 45(4):423–430. https://doi.org/10.3109/03602532.2013.835625
doi: 10.3109/03602532.2013.835625 pubmed: 24025091 pmcid: 5127714
Cook I, Wang T, Almo SC, Kim J, Falany CN, Leyh TS (2013) The gate that governs sulfotransferase selectivity. Biochemistry 52(2):415–424. https://doi.org/10.1021/bi301492j
doi: 10.1021/bi301492j pubmed: 23256751
Wang T, Cook I, Leyh TS (2014) 3′-Phosphoadenosine 5′-phosphosulfate allosterically regulates sulfotransferase turnover. Biochemistry 53(44):6893–6900. https://doi.org/10.1021/bi501120p
doi: 10.1021/bi501120p pubmed: 25314023
Cook I, Wang T, Falany CN, Leyh TS (2015) The allosteric binding sites of sulfotransferase 1A1. Drug Metab Dispos 43(3):418–423. https://doi.org/10.1124/dmd.114.061887
doi: 10.1124/dmd.114.061887 pubmed: 25534770 pmcid: 4352582
Wang T, Cook I, Leyh TS (2016) Design and interpretation of human sulfotransferase 1A1 assays. Drug Metab Dispos 44(4):481–484. https://doi.org/10.1124/dmd.115.068205
doi: 10.1124/dmd.115.068205 pubmed: 26658224 pmcid: 4810762
Cook I, Wang T, Falany CN, Leyh TS (2012) A nucleotide-gated molecular pore selects sulfotransferase substrates. Biochemistry 51(28):5674–5683. https://doi.org/10.1021/bi300631g
doi: 10.1021/bi300631g pubmed: 22703301
Ambadapadi S, Wang PL, Palii SP, James MO (2015) Celecoxib influences steroid sulfonation catalyzed by human recombinant sulfotransferase 2A1. J Steroid Biochem Mol Biol 152:101–113. https://doi.org/10.1016/j.jsbmb.2015.05.003
doi: 10.1016/j.jsbmb.2015.05.003 pubmed: 25960318 pmcid: 4501872
Duffel MW, Marshal AD, McPhie P, Sharma V, Jakoby WB (2001) Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab Rev 33(3–4):369–395. https://doi.org/10.1081/DMR-120001394
doi: 10.1081/DMR-120001394 pubmed: 11768773
Qin X, Teesch LM, Duffel MW (2013) Modification of the catalytic function of human hydroxysteroid sulfotransferase hSULT2A1 by formation of disulfide bonds. Drug Metab Dispos 41(5):1094–1103. https://doi.org/10.1124/dmd.112.050534
doi: 10.1124/dmd.112.050534 pubmed: 23444386 pmcid: 3629806
Gamage NU, Duggleby RG, Barnett AC, Tresillian M, Latham CF, Liyou NE, McManus ME, Martin JL (2003) Structure of a human carcinogen-converting enzyme, SULT1A1. Structural and kinetic implications of substrate inhibition. J Biol Chem 278(9):7655–7662. https://doi.org/10.1074/jbc.M207246200 . M207246200 [pii]
doi: 10.1074/jbc.M207246200 pubmed: 12471039
Wang LQ, Lehmler HJ, Robertson LW, Falany CN, James MO (2005) In vitro inhibition of human hepatic and cDNA-expressed sulfotransferase activity with 3-hydroxybenzo[a]pyrene by polychlorobiphenylols. Environ Health Perspect 113(6):680–687
doi: 10.1289/ehp.7837
Squirewell EJ, Qin X, Duffel MW (2014) Endoxifen and other metabolites of tamoxifen inhibit human hydroxysteroid sulfotransferase 2A1 (hSULT2A1). Drug Metab Dispos 42(11):1843–1850. https://doi.org/10.1124/dmd.114.059709
doi: 10.1124/dmd.114.059709 pubmed: 25157097 pmcid: 4201133
Sundaram RS, Szumlanski C, Otterness D, van Loon JA, Weinshilboum RM (1989) Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form. Drug Metab Dispos 17(3):255–264
pubmed: 2568905
Tong Z, James MO (2000) Purification and characterization of hepatic and intestinal phenol sulfotransferase with high affinity for benzo[a]pyrene phenols from channel catfish, Ictalurus punctatus. Arch Biochem Biophys 376(2):409–419
doi: 10.1006/abbi.2000.1746

Auteurs

Margaret O James (MO)

Department of Medicinal Chemistry, University of Florida, Gainesville, FL, USA. mojames@ufl.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH